Trieu Vuong bought OTLC
November 22, 2024 · Form 4 insider transaction
Trieu Vuong bought 298,499 shares of Oncotelic Therapeutics, Inc. at $0.03 per share, a transaction worth $8.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
298,499
Price
$0.03
Total value
$8.6K
InsiderTrieu Vuong
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 22, 2024
Filing dateNovember 26, 2024
Shares owned after92,842,716
OwnershipDirect
10b5-1 planNo
AmendedNo